443 related articles for article (PubMed ID: 17049837)
1. Therapeutic peptides: technological advances driving peptides into development.
Sato AK; Viswanathan M; Kent RB; Wood CR
Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
[TBL] [Abstract][Full Text] [Related]
2. Discovering and improving novel peptide therapeutics.
McGregor DP
Curr Opin Pharmacol; 2008 Oct; 8(5):616-9. PubMed ID: 18602024
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic peptides.
Lien S; Lowman HB
Trends Biotechnol; 2003 Dec; 21(12):556-62. PubMed ID: 14624865
[No Abstract] [Full Text] [Related]
4. Phage display-derived peptides as therapeutic alternatives to antibodies.
Ladner RC; Sato AK; Gorzelany J; de Souza M
Drug Discov Today; 2004 Jun; 9(12):525-9. PubMed ID: 15183160
[TBL] [Abstract][Full Text] [Related]
5. Antibody engineering and modification technologies.
Filpula D
Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
[TBL] [Abstract][Full Text] [Related]
6. Peptide-based drug design: here and now.
Otvos L
Methods Mol Biol; 2008; 494():1-8. PubMed ID: 18726565
[TBL] [Abstract][Full Text] [Related]
7. Vaccine manufacturing: challenges and solutions.
Ulmer JB; Valley U; Rappuoli R
Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. Macromolecular therapeutics: emerging strategies for drug discovery in the postgenome era.
Juliano RL; Astriab-Fisher A; Falke D
Mol Interv; 2001 Apr; 1(1):40-53. PubMed ID: 14993337
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of molecular cancer therapeutics.
van Montfort RL; Workman P
Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
[TBL] [Abstract][Full Text] [Related]
11. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
Meade BR; Dowdy SF
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
[TBL] [Abstract][Full Text] [Related]
12. Integrating cell-level kinetic modeling into the design of engineered protein therapeutics.
Rao BM; Lauffenburger DA; Wittrup KD
Nat Biotechnol; 2005 Feb; 23(2):191-4. PubMed ID: 15696150
[TBL] [Abstract][Full Text] [Related]
13. Macromolecular versus small-molecule therapeutics: drug discovery, development and clinical considerations.
Cho MJ; Juliano R
Trends Biotechnol; 1996 May; 14(5):153-8. PubMed ID: 8645449
[TBL] [Abstract][Full Text] [Related]
14. Molecular targets and cancer therapeutics.
Westwell AD
Drug Discov Today; 2004 Dec; 9(24):1042-4. PubMed ID: 15582792
[No Abstract] [Full Text] [Related]
15. Application of proteomics in biotechnology--microbial proteomics.
Josic D; Kovac S
Biotechnol J; 2008 Apr; 3(4):496-509. PubMed ID: 18320565
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting protein-protein interactions using designed molecules.
Zhao L; Chmielewski J
Curr Opin Struct Biol; 2005 Feb; 15(1):31-4. PubMed ID: 15718130
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic application of peptides and proteins: parenteral forever?
Antosova Z; Mackova M; Kral V; Macek T
Trends Biotechnol; 2009 Nov; 27(11):628-35. PubMed ID: 19766335
[TBL] [Abstract][Full Text] [Related]
18. Advances in strategies to improve drug delivery to brain tumors.
Newton HB
Expert Rev Neurother; 2006 Oct; 6(10):1495-509. PubMed ID: 17078789
[TBL] [Abstract][Full Text] [Related]
19. The Fourth International Peptide Symposium: discovery to drugs: the peptide pipeline.
Benson H; Toth I
Biopolymers; 2008; 90(5):588. PubMed ID: 18821571
[No Abstract] [Full Text] [Related]
20. Ligand-based vascular targeting of disease.
Rybak JN; Trachsel E; Scheuermann J; Neri D
ChemMedChem; 2007 Jan; 2(1):22-40. PubMed ID: 17154429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
